Hengeler Mueller advised Proteros’ majority shareholder on the transaction. Proteros biostructures GmbH, a leading Germany-based contract research organisation focused on early-stage drug discovery, has won a...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here